Journal: Oncology Letters

Article Title: Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review

doi: 10.3892/ol.2024.14633

Figure Lengend Snippet: Right ovary with metastatic low-grade appendiceal mucinous neoplasm. Immunohistochemical staining for (A) caudal type homeobox 2, (B) cytokeratin 20 and (C) paired box gene 8. Magnification, ×100.

Article Snippet: Antigen retrieval by microwave and blocking of endogenous peroxidase activity (by 1% hydrogen peroxide in distillated water for 10 min at room temperature) was conducted before incubation with the following primary antibodies: CK20 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA777; DAKO; Agilent Technologies, Inc.), CDX2 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA080; DAKO; Agilent Technologies, Inc.) and PAX8 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. 760-4618; Roche Diagnostics) at 4°C overnight.

Techniques: Immunohistochemical staining, Staining

Journal: Oncology Letters

Article Title: Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review

doi: 10.3892/ol.2024.14633

Figure Lengend Snippet: Expression patterns of the most common immunohistochemistry markers depending on the origin of the tumor.

Article Snippet: Antigen retrieval by microwave and blocking of endogenous peroxidase activity (by 1% hydrogen peroxide in distillated water for 10 min at room temperature) was conducted before incubation with the following primary antibodies: CK20 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA777; DAKO; Agilent Technologies, Inc.), CDX2 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA080; DAKO; Agilent Technologies, Inc.) and PAX8 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. 760-4618; Roche Diagnostics) at 4°C overnight.

Techniques: Expressing, Immunohistochemistry

Journal: Oncology Letters

Article Title: Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review

doi: 10.3892/ol.2024.14633

Figure Lengend Snippet: Expression patterns of concomitant IHC markers in POMN and APE.

Article Snippet: Antigen retrieval by microwave and blocking of endogenous peroxidase activity (by 1% hydrogen peroxide in distillated water for 10 min at room temperature) was conducted before incubation with the following primary antibodies: CK20 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA777; DAKO; Agilent Technologies, Inc.), CDX2 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. GA080; DAKO; Agilent Technologies, Inc.) and PAX8 (monoclonal mouse anti-human antibody; ready-to-use; cat. no. 760-4618; Roche Diagnostics) at 4°C overnight.

Techniques: Expressing

Journal: Cureus

Article Title: Primary Mucinous Adenocarcinoma of the Renal Pelvis: A Case Report

doi: 10.7759/cureus.62709

Figure Lengend Snippet: CDX2 expression showing strong diffuse nuclear staining on IM (square) and focal weal staining on clusters of signet ring cells (square). Original magnification 40x, 100x, 100x.

Article Snippet: CDX2 CDX2 IHC was performed on formalin-fixed paraffin-embedded tissues using the DAKO Monoclonal Mouse Anti-Human CDX2 antibody (DAKO California, USA) at a 1:50 dilution.

Techniques: Expressing, Staining

Journal: ESMO Open

Article Title: Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer

doi: 10.1136/esmoopen-2020-000847

Figure Lengend Snippet: Disease-free survival (DFS) according to CDX2 expression. Kaplan-Meier estimate of DFS by CDX2 expression. P value determined by log-rank test.

Article Snippet: CDX2 immunostaining was carried out with a primary mouse anti-human CDX2 monoclonal antibody (clone DAK-CDX2, prediluted, Dako).

Techniques: Expressing

Journal: ESMO Open

Article Title: Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer

doi: 10.1136/esmoopen-2020-000847

Figure Lengend Snippet: Cox regression model to evaluate recurrence-free survival based on patients’ characteristics including ctDNA status

Article Snippet: CDX2 immunostaining was carried out with a primary mouse anti-human CDX2 monoclonal antibody (clone DAK-CDX2, prediluted, Dako).

Techniques: